SCHEMBL6449865

SCHEMBL6449865

[CH2]CCCCCCC/C=C/C=C/C=C/CC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
TSHR P16473 1/20 0.43
FASN P49327 1/20 0.38
F7 P08709 2/20 0.33
F3 P13726 2/20 0.33
MAPT P10636 2/20 0.33
CYP19A1 P11511 2/20 0.33
KDM4E B2RXH2 2/20 0.33
OXER1 Q8TDS5 1/20 0.33
TRPA1 O75762 1/20 0.33
MEN1 O00255 1/20 0.33
FFAR1 O14842 1/20 0.33
NR1I2 O75469 1/20 0.33
LMNA P02545 1/20 0.33
PLA2G1B P04054 1/20 0.33
CYP3A4 P08684 1/20 0.33
HPGD P15428 1/20 0.33
ALOX15 P16050 1/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7524781 1.00 ALDH1A1 (0.43) ALDH1A1TSHRFASNF7F3
SCHEMBL6009638 1.00 ALDH1A1 (0.43) ALDH1A1TSHRFASNF7F3
SCHEMBL28731028 1.00 ALDH1A1 (0.43) ALDH1A1TSHRFASNF7F3
SCHEMBL6449868 1.00 ALDH1A1 (0.43) ALDH1A1TSHRFASNF7F3
SCHEMBL11511291 1.00 ALDH1A1 (0.43) ALDH1A1TSHRFASNF7F3
SCHEMBL6009640 1.00 ALDH1A1 (0.43) ALDH1A1TSHRFASNF7F3
SCHEMBL11511290 1.00 ALDH1A1 (0.43) ALDH1A1TSHRFASNF7F3
SCHEMBL6816149 1.00 ALDH1A1 (0.43) ALDH1A1TSHRFASNF7F3
SCHEMBL18300536 1.00 ALDH1A1 (0.43) ALDH1A1TSHRFASNF7F3
SCHEMBL25185214 0.98 ALDH1A1 (0.40) ALDH1A1TSHRFASNF7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1592415-A2 THERAPEUTICALLY ACTIVE COMPOUNDS Encore Pharmaceuticals, Inc (US) 2005-11-09 EP disclosed
US-20040151758-A1 Fat substitutes ENCORE PHARMACEUTICALS, INC. 2004-08-05 US disclosed
WO-2004064761-A2 THERAPEUTICALLY ACTIVE COMPOUNDS ENCORE PHARMACEUTICALS, INC. (US) 2004-08-05 WO disclosed
US-20040152777-A1 Therapeutically active compounds ENCORE PHARMACEUTICALS, INC. 2004-08-05 US disclosed